Where Should African Patients Go for Sickle Cell Treatment? Comparing India, Turkey, and the UAE

Sickle Cell Disease (SCD) is one of the most prevalent inherited blood disorders in Africa, particularly in Nigeria, Ghana, Uganda, Kenya, Tanzania, Zimbabwe, Cameroon and Zambia. Although most patients can manage this chronic condition locally, patients with SCD who have complex care needs frequently travel to other countries to obtain state-of-the-art medical services and access advanced treatment options available only in speciality centres (e.g., bone marrow transplantation, multidisciplinary care, long-term disease management).

India, Turkey, and the United Arab Emirates are three of the most sought-after destinations for patients seeking international care for individuals with SCD. Each of these countries provides modern healthcare facilities, experienced healthcare professionals, and dedicated services to assist international patients.

However, many factors must be taken into account when determining which destination will provide the best treatment options, available resources and at affordable rates, as well as treatment options, availability of affordable transportation, wait times for the treatment to begin, and convenience of travelling and returning to your home country (for follow-up visits).

This guide will provide information to assist patients in Africa in determining whether to seek care in another country for treatment of SCD.

When Should You Seek Treatment In A Foreign Country?

You may wish to consider travelling to another country for the treatment of SCD if you are experiencing any of the following symptoms:

• Recurrent painful episodes caused by the blockage of blood flow to various sites in the body (i.e., vaso-occlusive crises)
• Frequent hospital admissions due to SCD complications
• History of strokes or very high risk for experiencing a stroke in the future (CVA)
• Episodes of acute chest syndrome
• SCD-related anaemia that requires frequent transfusions
• Organs that are not functioning properly due to lack of blood flow (kidneys, lungs, heart, and Liver)

Limited access to healthcare facilities that provide hematologic specialists in your local community.

The term "travelling for treatment" does not necessarily mean you will have surgery performed on yourself. Patients who travel overseas for medical services may do so for expert advice regarding their medical condition; to have a full evaluation completed, to undergo advanced diagnostic testing, or to establish long-term treatment of a chronic disease.

Treatment Options

In sickle cell disease (SCD), current therapeutic approaches focus on preventing complications to optimise patients' quality of life. Treatment for SCD may range from mild to severe and will include some or all of the following:

• Specialist (haematologist) consultation
• Hydroxyurea therapy
• Transfusion programme (blood transfusions)
• Exchange transfusions
• Pain relief
• Prevention of infection
• Monitoring of all organs for functionality
• Stroke prevention
• Bone marrow/haematopoietic stem cell transplant
• Genetic counselling
• Comprehensive rehabilitation

In some centres, advanced cellular therapies and clinical trials may be available where applicable.

How to Choose the Right Hospital and Doctor

It is essential that you choose the right hospital for optimal management of sickle cell disease. Hospitals with specialised hematology and/or bone marrow transplant facilities, advanced laboratories for diagnosis, intensive care units, blood banks, pediatric care (if applicable), infectious disease specialists, emergency departments, and international patient programs are ideal.

A multidisciplinary team of professionals will provide comprehensive care for long-term complications arising from sickle cell disease.

Hospitals in India:

1. BLK-Max Super Speciality Hospital
2. Artemis Health Institute
3. Medanta - The Medicity
4. Gleneagles Hospital Mumbai
5. Apollo Hospitals

Hospitals in Turkey:

1. Medipol Bahçelievler Hospital
2. Florence Nightingale Hospital
3. Istinye University Medical Park Gaziosmanpasa Hospital
4. Liv Hospital Ulus
5. Medicana International Samsun Hospital

Hospitals in UAE:

1. King's College Hospital Dubai
2. Prime Hospital
3. Burjeel Hospital, Abu Dhabi

Questions to Ask Before Choosing a Hospital

• Does the hospital regularly treat sickle cell disease?
• Is a hematologist available throughout treatment?
• Is stem cell transplantation offered if needed?
• What investigations will be required?
• What complications can be managed on-site?
• How long will treatment take?
• What are the expected costs?
• Is teleconsultation available after returning home?
• Will my local doctor receive follow-up reports?

Choosing the right Doctor

When using sickle cell disease for any treatment, whether it’s for domestic or internationally-based therapies you wish to have performed abroad, finding an experienced haematologist who can thoroughly assess your condition, provide appropriate options for care, work with other professionals when needed and provide ongoing follow up care is extremely important; this is especially true if you plan to pursue advanced procedures such as bone marrow transplantation (BMT).

You’ll also want to make sure that your physician is on a multidisciplinary team of physicians with the training and experience needed to provide high-quality BMT care, as well as the ability to follow the patient through their recovery after receiving BMT.

When selecting your physician, here are some of the most important things to consider:

• Extent of the physician's experience with treating sickle cell disease
• The physician's experience and/or training in BMT, if necessary
• Affiliation of the physician and the centre where they practice specialised haematology
• Multi-disciplinary approach to developing and delivering patient care
• The physician's experience with treating patients from outside the U.S.
• The availability of telemedicine consultation services
• The availability of services to continue follow-up care through telemedicine

The ability of the physician to provide clear communication with you so that you will have an individualised treatment plan drawn up based on your unique needs and medical and laboratory findings that you will be able to understand regardless of where you are from.

Planning for International Treatment

Prior to international travel, patients are encouraged to consider the following preparations for international travel:

• Passport
• Medical visa (if required)
• Medical reports
• Blood test results
• Imaging studies
• Current medications
• Vaccines received
• Insurance documents
• Emergency contacts

Patients with sickle cell disease should discuss their fitness for travel with their doctor. Prolonged travel, dehydration and infections can trigger sickle cell crises.

Travel Considerations for Patients with Sickle Cell Disease from Africa

Patients with sickle cell disease require additional precautions when travelling internationally. During their travel, patients with sickle cell disease should consider the following recommendations:

• Stay well-hydrated.
• Avoid high-temperature environments.
• Carry all medications with you in your carry-on luggage.
• Keep all medical records readily accessible.
• Walk frequently if flying for an extended period.
• Inform an airline employee if assistance is needed.
• Seek immediate medical attention if fever, severe pain, or difficulty breathing occurs.

By properly planning travel and having support available after surgery, the likelihood of travel-related complications is greatly reduced.

Recovering After Receiving Treatment

The time required to recover after treatment at an international facility depends on the type of treatment received. Patients who receive routine evaluations will generally return home within a few days, while patients who receive bone marrow transplants may require extended follow-up after treatment at the facility.

In general, recovering from treatment abroad will include the following:

• Frequent blood monitoring
• Adjustment of medications
• Preventing infection
• Receiving nutritional support
• Receiving physical therapy, if necessary
• Teleconsultation follow-up
• Coordinating care with doctors in the local area

Ongoing monitoring of sickle cell patients is essential for successful long-term management; a single hospital visit is insufficient.

Conclusion

Patients from Africa seeking appropriate treatment for their sickle cell disease can consider India, Turkey, and the United Arab Emirates as options for world-class research and care. An individual should assess the appropriate venue based on their own health condition, narrative, travel plans, and budget.

Obtaining the appropriate opinion from a professional in hematology and creating an individualised treatment plan; as well as comparing hospitals/clinics by their expertise and not simply the cost; will assist individuals in making an informed decision on whether or not to proceed with international care.

A well-thought-out plan, along with an appropriately trained medical team, will enable sickle cell patients who travel internationally to access the most advanced therapies, improve their overall health, and live healthy lives with sickle cell.